Upgrade to SI Premium - Free Trial

Citi continue to see upside to Eli Lilly & Co.'s (LLY) 'already rich' valuation

November 2, 2023 11:11 AM
Citi analyst Andrew Baum said in a note Thursday that the Mounjaro beat for Eli Lilly & Co. (NYSE: LLY) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Hot List

Next Articles